Chronic obstructive pulmonary disease: towards pharmacogenetics.
about
The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.Treatment options for moderate-to-very severe chronic obstructive pulmonary disease.Genetic Association of Pulmonary Surfactant Protein Genes, SFTPA1, SFTPA2, SFTPB, SFTPC, and SFTPD With Cystic FibrosisMarkers of Oxidative Stress in the Exhaled Breath Condensate of Workers Handling Nanocomposites
P2860
Chronic obstructive pulmonary disease: towards pharmacogenetics.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@ast
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@en
type
label
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@ast
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@en
prefLabel
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@ast
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@en
P2093
P2860
P356
P1433
P1476
Chronic obstructive pulmonary disease: towards pharmacogenetics.
@en
P2093
Alice M Wood
Robert A Stockley
See Ling Tan
P2860
P2888
P356
10.1186/GM112
P577
2009-11-30T00:00:00Z
P5875
P6179
1000926538